The UK’s approach to weight management has shifted permanently. After decades of ineffective fad diets, calorie restriction plans, and surgical options reserved for the most severe cases, a new class of medications has arrived that is genuinely changing lives. GLP-1 receptor agonists — the science behind Mounjaro and Wegovy — are now the most talked-about medical breakthrough in weight loss, and for very good reason.
Whether you have been searching for GLP-1 weight loss UK options, wondering about GLP-1 weight loss on the NHS, or trying to understand how these medications actually work in your body, this guide covers everything you need to know. At PPRX, we provide clinically supported access to Mounjaro and Wegovy alongside a full wellness programme — because a prescription alone is never the complete answer.
What Is a GLP-1 Receptor Agonist? A UK Patient’s Guide to GLP-1 Weight Loss
Glucagon-like peptide-1 (GLP-1) is a natural hormone your body produces in the gut after eating. Its job is to signal to the brain that you are full, slow the emptying of your stomach, and help regulate blood sugar by stimulating insulin release. For many people living with obesity, this hormonal signalling system is out of balance — which is why hunger feels relentless and portion control alone rarely delivers lasting results.
GLP-1 receptor agonists are synthetic versions of this hormone. Administered as weekly injections (or, in some cases, daily tablets), they bind to the same receptors in the brain and digestive system, recreating and amplifying those satiety signals. The result is a significant, sustained reduction in appetite, lower calorie intake, and measurable weight loss — without the willpower battles that crash diets demand.
Some newer medications go even further. Mounjaro (tirzepatide), available through PPRX, is a dual receptor agonist that activates not only the GLP-1 receptor but also the GIP (glucose-dependent insulinotropic polypeptide) receptor. This dual action produces even more powerful effects on appetite regulation and metabolic function, which is why the SURMOUNT clinical trials showed average weight loss of around 20% of body weight in some patient groups — a result that was previously only achievable through bariatric surgery.
All GLP-1 medications available in the UK are regulated by the Medicines and Healthcare products Regulatory Agency (MHRA). They are prescription-only medicines, meaning they must be issued by a qualified healthcare professional following a clinical consultation.
The Top 10 GLP-1 Medications Available in the UK for Weight Loss
The market for GLP-1 medications is growing rapidly. Here is an honest, up-to-date overview of every major option — including those currently licensed, those used off-label, and those in the pipeline — to help you understand the landscape.
| 1 | Mounjaro (Tirzepatide) | Weight Loss + Diabetes | Dual GLP-1/GIP action — strongest evidence to date |
| 2 | Wegovy (Semaglutide 2.4mg) | Weight Loss | Up to 15% body weight loss in STEP trials |
| 3 | Ozempic (Semaglutide 1mg) | Type 2 Diabetes | Off-label weight loss use — not licensed for it |
| 4 | Rybelsus (Oral Semaglutide) | Type 2 Diabetes | Only oral semaglutide currently licensed in UK |
| 5 | Saxenda (Liraglutide 3mg) | Weight Loss | Currently limited availability in UK |
| 6 | Victoza (Liraglutide 1.2/1.8mg) | Type 2 Diabetes | Older GLP-1; once-daily injection |
| 7 | Oral Semaglutide 25mg | Pipeline | Under regulatory review; not yet MHRA-approved |
| 8 | Orforglipron | Pipeline | Small-molecule pill; no injection needed |
| 9 | Mysimba (Naltrexone/Bupropion) | Weight Loss | Non-GLP-1; included for comparison |
| 10 | Orlistat | Weight Loss | Oldest option; blocks fat absorption; OTC available |
Important note: PPRX currently prescribes Mounjaro and Wegovy — the two most clinically advanced and MHRA-licensed weight loss options available in the UK today. Both medications have robust trial evidence and established safety profiles, making them the clear first-choice options for eligible patients.
GLP-1 Dosage for Weight Loss — What to Expect at Every Stage
One of the most common questions patients ask is how much GLP-1 medication they will need to take. Both Mounjaro and Wegovy follow a carefully structured dose escalation schedule, starting low and gradually increasing over several months. This approach is essential for managing side effects — primarily nausea — while allowing your body to adapt.
Mounjaro (Tirzepatide) Dose Schedule
- 2.5mg weekly — Months 1 and 2 (starting dose, tolerance building)
- 5mg weekly — Months 3 and 4
- 7.5mg weekly — Months 5 and 6
- 10mg weekly — Months 7 and 8
- 12.5mg weekly — Months 9 and 10
- 15mg weekly — Month 11 onwards (maximum maintenance dose)
Wegovy (Semaglutide) Dose Schedule
- 0.25mg weekly — Weeks 1 to 4 (initiation dose)
- 0.5mg weekly — Weeks 5 to 8
- 1mg weekly — Weeks 9 to 12
- 1.7mg weekly — Weeks 13 to 16
- 2.4mg weekly — Week 17 onwards (maintenance dose)
The STEP clinical trials for semaglutide showed that patients achieving the 2.4mg maintenance dose lost an average of 14.9% of their body weight over 68 weeks. The SURMOUNT-1 trial for tirzepatide at 15mg showed average weight reduction of 20.9% — numbers that represent a genuine step change in what is medically achievable without surgery.
At PPRX, your prescribing clinician will review your progress at each stage of the titration process, ensuring your dose is appropriate for your response and any side effects you experience.
GLP-1 Weight Loss NHS — Who Qualifies and What Are the Criteria?
Access to GLP-1 medications through the NHS has expanded significantly since 2025, but eligibility remains strictly controlled. NHS England has implemented a phased rollout approach, prioritising patients with the highest clinical need first.
Current NHS Mounjaro (Tirzepatide) Eligibility — Cohort Structure
- Cohort 1: BMI 40+ with at least four weight-related comorbidities (e.g., type 2 diabetes, hypertension, sleep apnoea)
- Cohort 2: BMI 37.5+ with at least three comorbidities (phased expansion)
- Cohort 3: BMI 35+ with at least two comorbidities (further expansion expected)
- All cohorts: Mandatory enrolment in a 9-month Healthier You Behavioural Support Programme
As of early 2026, NHS England estimates that approximately 220,000 patients will become eligible across the first three years of the programme. At a typical GP practice, this represents fewer than 50 patients — a small fraction of those who could benefit.
Wegovy (semaglutide) remains available through NHS Specialist Weight Management Services under separate criteria, typically requiring referral from a GP and a BMI above 35 with at least one weight-related health condition.
If you do not currently meet the NHS eligibility thresholds, or if you would prefer not to wait for the phased rollout to reach your cohort, a private prescription from PPRX provides safe, regulated access to both Mounjaro and Wegovy with no waiting list.
GLP-1 Weight Loss UK — Where to Buy Safely and What to Avoid
The surge in demand for GLP-1 medications has unfortunately created a parallel market of unregulated and counterfeit products. Understanding where to buy safely is not simply a matter of convenience — it is a genuine patient safety issue.
Where GLP-1 Medications Are Safe to Purchase
- GPhC-registered online pharmacies (such as PPRX) — always verify registration at pharmacyregulation.org
- NHS prescriptions fulfilled at registered high street or online pharmacies
- Private prescriptions from CQC-registered clinics and GMC-registered prescribers
Where You Must Never Purchase GLP-1 Medications
- Beauty salons or aesthetics clinics not registered as pharmacies
- Social media marketplaces (Instagram, TikTok, Facebook)
- International websites without UK regulatory approval
- Any source supplying powder in vials requiring reconstitution — these products are not MHRA-authorised
Counterfeit GLP-1 injections have been reported to the MHRA and have resulted in serious adverse events in patients across the UK. Legitimate products from Novo Nordisk (Wegovy) and Eli Lilly (Mounjaro) are supplied exclusively as pre-filled, single-use injection pens. If you receive anything else, do not use it.
When you order through PPRX, every product in our supply chain is sourced directly from the UK-authorised distributor, arrives in original manufacturer packaging, and is dispensed only after a clinical consultation has confirmed your suitability.
GLP-1 Oral Solution UK — What Are the Options Right Now?
The search for GLP 1 weight loss oral solution UK options is one of the fastest-growing queries in this space, and it reflects a very real patient preference: many people are understandably hesitant about weekly injections and would prefer a tablet or liquid alternative.
Here is an honest breakdown of where oral GLP-1 options currently stand in the UK:
- Rybelsus (oral semaglutide, 3mg / 7mg / 14mg) — currently licensed in the UK, but exclusively for type 2 diabetes management, not weight loss. It is not approved by the MHRA for obesity treatment.
- Oral semaglutide 25mg — a higher-dose formulation that has shown promising weight loss results in trials. It is under regulatory review in the United States and Europe; MHRA approval for UK use is anticipated but not yet granted.
- Orforglipron — a small-molecule, non-peptide GLP-1 receptor agonist that could eventually be taken as a daily pill without food restrictions. Phase 3 trials are ongoing; no UK approval exists yet.
- Unregulated oral GLP-1 liquids — several products sold online claim to deliver GLP-1 effects via drops or sublingual solutions. None of these are MHRA-licensed. The MHRA has specifically warned against their use.
The GLP-1 oral liquid reviews UK patients sometimes find online typically refer to unlicensed compounded products or overseas supplements. These are not equivalent to pharmaceutical-grade semaglutide or tirzepatide and carry unknown risks.
PPRX is committed to expanding our oral GLP-1 offering as soon as clinically validated, MHRA-approved options become available. Until then, injectable Mounjaro and Wegovy remain the gold standard — and the evidence for their safety and effectiveness is stronger than for any oral alternative currently on the market.
GLP-1 Price UK — How Much Does Mounjaro and Wegovy Cost in 2026?
Pricing is one of the most important practical considerations for anyone starting a GLP-1 treatment programme. Below is a transparent overview of current UK costs, based on 2026 market rates:
| Mounjaro (Private) | ~£149/month | £300–£375/mo | £2,500–£4,200 | Prescription + Support |
| Wegovy (Private) | ~£119/month | £249–£295/mo | £1,800–£3,500 | Prescription + Support |
| NHS (Eligible Only) | Free (£9.90 charge) | Free | — | Specialist Programme |
A few important points on pricing. The cost of Mounjaro increased in September 2025 following Eli Lilly’s UK pricing revision. Both Mounjaro and Wegovy require ongoing prescriptions — they are not one-time treatments. Most patients see meaningful weight loss within the first three months, with maximum effect typically reached around months six to twelve.
At PPRX, our pricing includes clinical consultation, prescription issuance, and ongoing prescriber oversight. We also offer bundled packages that incorporate our online meal planning service and personal training support — because the clinical evidence consistently shows that GLP-1 medications produce significantly better long-term outcomes when combined with structured lifestyle support.
Beyond the Injection — PPRX’s Complete GLP-1 Weight Loss Programme
PPRX is not simply a prescription service. We believe that sustainable weight loss requires support at every level — medical, nutritional, physical, and cosmetic. Our complete programme reflects that philosophy.
Prescription Medications
- Mounjaro (Tirzepatide) — the most advanced GLP-1/GIP dual agonist available in the UK, clinically proven to deliver up to 20% body weight reduction
- Wegovy (Semaglutide 2.4mg) — the gold-standard GLP-1 for weight management, with a well-established safety profile and NICE-approved status
Lifestyle and Nutrition Support
- Online Meal Plans — nutritionist-designed eating programmes specifically calibrated for patients on GLP-1 therapy. GLP-1 medications significantly reduce appetite and change food preferences; our plans ensure you are still meeting your nutritional requirements while in a calorie deficit
- Online Personal Trainer — exercise programming tailored to your weight loss stage. Resistance training is particularly important during GLP-1 treatment to preserve lean muscle mass as fat is lost
Hair and Aesthetic Support
- Hair Oil for Hair Loss — telogen effluvium (temporary hair shedding) is a recognised side effect of rapid weight loss, including weight loss induced by GLP-1 medications. Our specialist hair oil is formulated to support scalp health and hair regrowth during your treatment journey
- Bimatoprost — a clinically proven topical treatment for eyelash and eyebrow restoration, helping patients maintain confidence throughout their body transformation
Coming Soon at PPRX
- Minoxidil — expanding our hair loss range with topical minoxidil solution for male and female pattern hair loss
- Dutasteride Hair Spray — advanced DHT-blocking spray for scalp application
- Beard Spray and Hair Gel — grooming products formulated for patients experiencing hair-related concerns
No other UK provider combines GLP-1 prescriptions with meal planning, fitness coaching, and aesthetic support under one roof. At PPRX, your transformation is supported at every step.
Experience, Expertise, Authority, Trust — Why Choose PPRX for GLP-1 in the UK?
Choosing a provider for prescription weight loss medication is a significant decision. At PPRX, we meet the highest standards of clinical governance and regulatory compliance, and we are transparent about exactly what that means.
| E-E-A-T Pillar | How PPRX Delivers It |
| Experience | PPRX has supported UK patients through medically supervised weight loss journeys, combining prescription access with lifestyle coaching, meal planning, and aesthetic support in one seamless service. |
| Expertise | All prescriptions are issued by UK-registered clinicians following NICE TA1026 guidance and MHRA licensing requirements. Mounjaro and Wegovy are prescribed only where clinically appropriate. |
| Authoritativeness | PPRX operates as a GPhC-registered online pharmacy, supplying only genuine, MHRA-approved medications via a fully regulated UK supply chain — never from unverified international sources. |
| Trustworthiness | Transparent pricing, no hidden charges, discreet packaging, and verified patient reviews. PPRX is committed to full clinical transparency at every stage of your treatment journey. |
Every patient who begins a GLP-1 programme through PPRX receives a personalised clinical consultation, a prescriber-reviewed treatment plan, and ongoing monitoring throughout their journey. We do not issue prescriptions without a proper consultation, and we do not prescribe to patients who do not meet the clinical criteria — because patient safety always comes before commercial opportunity.
Frequently Asked Questions About GLP-1 Weight Loss UK
Can I buy GLP-1 online in the UK without a prescription?
No. All GLP-1 receptor agonists are classified as prescription-only medicines (POMs) in the UK. Any website selling them without a prior consultation and prescriber-issued prescription is operating illegally. At PPRX, every order requires a completed clinical consultation reviewed by a registered prescriber.
Is Mounjaro or Wegovy better for weight loss?
Both are highly effective, but the clinical evidence currently favours Mounjaro (tirzepatide) for maximum weight loss, due to its dual GLP-1/GIP receptor action. The SURMOUNT trials showed average weight reduction of up to 20.9% at the 15mg dose, compared to approximately 14.9% with Wegovy at 2.4mg. However, the best medication for you depends on your individual health profile, medical history, and prescriber’s recommendation.
Are there GLP-1 tablets available in the UK?
The only oral GLP-1 currently licensed in the UK is Rybelsus (semaglutide), which is approved for type 2 diabetes — not weight loss. No oral GLP-1 tablet is currently MHRA-licensed for weight management. PPRX will update its product range as soon as clinically validated oral options are approved.
How long does it take to lose weight on GLP-1?
Most patients notice a meaningful reduction in appetite within the first two to four weeks. Measurable weight loss typically begins in the first four to eight weeks, with the most significant results seen between months three and twelve as the dose is escalated to the maintenance level. Clinical trials measured outcomes at 68 to 72 weeks for the most robust results.
What happens if I stop taking GLP-1 medication?
Weight regain is a well-documented outcome when GLP-1 medications are discontinued without having established sustainable lifestyle habits. This is precisely why PPRX integrates meal planning and personal training into your programme — so the behavioural foundations for long-term weight management are built alongside the medication.
Can GLP-1 cause hair loss?
Hair shedding (telogen effluvium) can occur during any period of significant calorie reduction or rapid weight loss, including that induced by GLP-1 medications. It is typically temporary. PPRX’s specialist hair oil is designed to support scalp health during this phase, and our hair loss range — expanding to include minoxidil — provides additional support for patients who are concerned.
Ready to Start Your GLP-1 Weight Loss Journey?
PPRX offers clinically supervised access to Mounjaro and Wegovy alongside
personalised meal plans, online personal training, and hair & aesthetic support.
Complete Your Online Consultation Today at PPRX.co.uk
